Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Patent
1990-12-21
1992-04-14
Ceperley, Mary E.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
436501, 436503, 540576, G01N 33567, C07D22316
Patent
active
051048140
ABSTRACT:
The invention describes a kit and a method useful for analyzing the plasma concentration of an active neuroleptic drug known to have D-1 receptor antagonist properties utilizing labeled [-]trans 6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo[d]naphtho-[2 ,1-b]-azepine.
REFERENCES:
patent: 4760029 (1988-07-01), Barnett et al.
Iorio et al., J. Pharm. Exp. Ther., vol. 226, No. 2, pp. 462-468 (1983).
Chipkin et al., J. Pharm. Exp. Ther., vol. 247, No. 3, pp. 1093-1102 (1988).
McQuade et al., J. Pharm. Exp. Ther., vol. 257, No. 1, pp. 42-48 (1991).
Chipkin Richard
McQuade Robert D.
Ceperley Mary E.
Lee, Jr. Warrick E.
Magatti Anita W.
Mazer Edward H.
Schering Corporation
LandOfFree
Assay kit and methods for neuroleptic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay kit and methods for neuroleptic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay kit and methods for neuroleptic drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2348878